1. PROTAC Immunology/Inflammation NF-κB MAPK/ERK Pathway
  2. PROTACs IRAK NF-κB p38 MAPK
  3. GSI526

GSI526 is a IRAK4 PROTAC degrader (DC50=40.17 nM, Dmax=97%; THP-1) based on the VHL ubiquitin-proteasome system. GSI526 inhibits IRAK4-mediated NF-κB and MAPK inflammatory signaling pathways, and induces IRAK4 degradation in myeloid cells. GSI526 is applicable to inflammation-related research.
(Pink: IRAK4 ligand (HY-183800); Blue: VHL ligand (HY-112078); Black: linker).

For research use only. We do not sell to patients.

GSI526

GSI526 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All PROTACs Isoform Specific Products:

View All IRAK Isoform Specific Products:

View All NF-κB Isoform Specific Products:

View All p38 MAPK Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

GSI526 is a IRAK4 PROTAC degrader (DC50=40.17 nM, Dmax=97%; THP-1) based on the VHL ubiquitin-proteasome system. GSI526 inhibits IRAK4-mediated NF-κB and MAPK inflammatory signaling pathways, and induces IRAK4 degradation in myeloid cells. GSI526 is applicable to inflammation-related research[1]. (Pink: IRAK4 ligand (HY-183800); Blue: VHL ligand (HY-112078); Black: linker).

IC50 & Target[1]

VHL

 

IRAK4

 

In Vitro

GSI526 (1-10000 nM; 24 h) induces dose-dependent degradation of IRAK4 in HEK293T cells with a DC50 of 50.89 nM and a Dmax greater than 80%[1].
GSI526 (0.01-30 μM; 24 h) exhibits no cytotoxicity in THP-1 cells at concentrations up to 30 μM following 24 h incubation[1].
GSI526 (0.01-30 μM; 48 h) exhibits no cytotoxicity in HEK293T cells at concentrations up to 30 μM following 48 h incubation[1].
GSI526 (1000 nM; 8 h) exhibits marked selectivity toward IRAK4 in THP-1 cells, with IRAK4 showing a statistically significant downregulation following 8 h treatment with 1000 nM GSI526[1].
GSI526 (1-5 μM; 1 h pretreatment, followed by 6 h LPS stimulation) inhibits LPS-induced activation of the IRAK4-NF-κB/MAPK signaling pathway in THP-1 cells via degradation of IRAK4[1].
GSI526 (0.3-3 μM; 1 h pretreatment, followed by 24 h LPS stimulation) dose-dependently inhibits LPS-induced expression of TNF-α and CXCL8 in THP-1 cells via suppression of the IRAK4-NF-κB/MAPK signaling pathway[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: THP-1 human monocytic leukemia cells
Concentration: 1-10000 nM (dose-response); 1 μM (time-course)
Incubation Time: 24 h (dose-response); 2-24 h (time-course)
Result: Induced dose-dependent degradation of IRAK4 with a DC50 of 40.17 nM and a maximum degradation (Dmax) of 97%.
Resulted in detectable IRAK4 degradation within 2 h, with maximal degradation achieved by 8 h, and the degradative effect was sustained for up to 24 h.

Western Blot Analysis[1]

Cell Line: HEK293T human embryonic kidney cells
Concentration: 1-10000 nM
Incubation Time: 24 h
Result: Induced dose-dependent degradation of IRAK4 with a DC50 of 50.89 nM and a Dmax greater than 80%.

Cell Viability Assay[1]

Cell Line: THP-1 human monocytic leukemia cells
Concentration: 0.01-30 μM
Incubation Time: 24 h
Result: Did not induce cytotoxic cell death at concentrations up to 30 μM.

Cell Viability Assay[1]

Cell Line: HEK293T human embryonic kidney cells
Concentration: 0.01-30 μM
Incubation Time: 48 h
Result: Did not induce cytotoxic cell death at concentrations up to 30 μM.

Western Blot Analysis[1]

Cell Line: THP-1 human monocytic leukemia cells
Concentration: 1-5 μM
Incubation Time: 1 h pretreatment, followed by 6 h LPS stimulation
Result: Inhibited LPS-induced phosphorylation of JNK, p38, ERK, and p65 (NF-κB) in a concentration-dependent manner via IRAK4 degradation.

Real Time qPCR[1]

Cell Line: THP-1 human monocytic leukemia cells
Concentration: 0.3-3 μM
Incubation Time: 1 h pretreatment, followed by 24 h LPS stimulation
Result: Significantly inhibited LPS-induced secretion of pro-inflammatory cytokine TNF-α and chemokine CXCL8, with the inhibitory effect particularly evident at 1 and 3 μM.
Molecular Weight

959.17

Formula

C51H62N10O7S

SMILES

O=C(C1=NC(C2=CC=NN2)=CC=C1)NC3=C(OC)C=C(N4CCC5(CN(C(CCCC(N[C@@H](C(C)(C)C)C(N6[C@H](C(N[C@@H](C)C7=CC=C(C8=C(C)N=CS8)C=C7)=O)C[C@@H](O)C6)=O)=O)=O)C5)CC4)C=C3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
GSI526
Cat. No.:
HY-183799
Quantity:
MCE Japan Authorized Agent: